Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gore

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
A new standard of care for treatment of ovarian cancerM J Piccart, A Du Bois, M E Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecanA N Gordon, J T Fleagle, D Guthrie, et al.
American Journal of Epidemiology|October 3, 2001
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohortsP M Tarwater, J Mellors, M E Gore, et al.
British Journal of Cancer|November 1, 1989
The impact of computed tomography and ultrasonography on the management of patients with carcinoma of the ovaryM E Gore, J C Cooke, E Wiltshaw, et al.
British Journal of Urology|July 1, 1994
Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomyG Dadian, P G Riches, D C Henderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patientsJ Chang, J C Sharpe, R P A'Hern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxelJ A Bridgewater, A E Nelstrop, G J Rustin, et al.
The British Journal of Dermatology|February 19, 2009
Revisiting the past: utilizing archival tissue for the detection and quantification of gene expressionS Singh, S Kaye, N D Francis, et al.
Melanoma Research|August 1, 1995
The histological and immunohistochemical changes in the skin of patients with melanoma who develop changes in skin pigmentation following immunotherapyJ Salter, K MacLennan, J A Bridgewater, et al.
British Journal of Cancer|May 3, 2002
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancerD D Gibbs, L Pyle, M Allen, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
A new standard of care for treatment of ovarian cancerM J Piccart, A Du Bois, M E Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecanA N Gordon, J T Fleagle, D Guthrie, et al.
American Journal of Epidemiology|October 3, 2001
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohortsP M Tarwater, J Mellors, M E Gore, et al.
British Journal of Cancer|November 1, 1989
The impact of computed tomography and ultrasonography on the management of patients with carcinoma of the ovaryM E Gore, J C Cooke, E Wiltshaw, et al.
British Journal of Urology|July 1, 1994
Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomyG Dadian, P G Riches, D C Henderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patientsJ Chang, J C Sharpe, R P A'Hern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxelJ A Bridgewater, A E Nelstrop, G J Rustin, et al.
The British Journal of Dermatology|February 19, 2009
Revisiting the past: utilizing archival tissue for the detection and quantification of gene expressionS Singh, S Kaye, N D Francis, et al.
Melanoma Research|August 1, 1995
The histological and immunohistochemical changes in the skin of patients with melanoma who develop changes in skin pigmentation following immunotherapyJ Salter, K MacLennan, J A Bridgewater, et al.
British Journal of Cancer|May 3, 2002
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancerD D Gibbs, L Pyle, M Allen, et al.
Pageof 16